WELCOME TO
A fresh approach to Life Science PR & Marketing
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
BIO 2020
Mon June 8 2020 -
Date
Thu June 11 2020
Location
-
BioProcess International Europe
Mon July 13 2020 - Date
Thu July 16 2020 Location
-
PEGS Boston
Mon August 31 2020 - Date
Fri September 4 2020 Location
This month, Zyme is celebrating its 10th anniversary! A huge thank you to our clients & partners - we have been privileged to support so many pioneering companies in the #lifesciences sector in this time. In celebration, please visit our new website, at: https://t.co/U3TJRVGprs
.@Dotmatics today announced it has received #ISO9001 accreditation for the company’s #science #informatics technology. This achievement demonstrates its commitment to #service and #quality to an international standard. Read more here: https://t.co/BJpteUyN74
Epigenetics company @BaseGenomics has launched with a team of leading #scientists & clinicians to set a new gold standard in #DNA methylation detection. The company has closed an oversubscribed #seedfunding round of $11million: https://t.co/nz159nTz9I @OSI_Updates #cancer
.@hel_group today announced the appointment of Mert Sahin as General Manager and Senior Vice President of North American Operations. https://t.co/iveVpxC98D
.@IAmBiotech has launched a #COVID19 resource centre to track latest updates in the development of therapeutics, vaccines and diagnostics. View the website here: https://t.co/ATBw06Sh12
This @Labiotech_eu article discusses how the #COVID19 pandemic is affecting Europe's #biotech stocks, and the importance of smaller companies and institutions in the fight against the virus. Read more here: https://t.co/0KpYmwNVLJ